Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$160,854
-$74,400 QoQ
Shares Held
6,680
-20.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,485
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jackson, Grant Investment Advisers, Inc. holds $16,628,871 across 11 Drug Manufacturers - General names. PFE ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
30,346 | $7,636,267 | |
| 2 | JNJ |
Johnson & Johnson
|
13,554 | $3,442,309 | |
| 3 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,533 | $1,610,490 | |
| 5 | AMGN |
Amgen Inc
|
2,382 | $862,569 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,529 | $203,340 | |
| 7 | PFE |
Pfizer Inc
This page
|
6,680 | $160,854 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,035 | $130,761 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $160,854 | 6,680 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $235,254 | 8,378 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $223,851 | 8,990 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $283,592 | 11,130 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $240,678 | 9,929 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $250,232 | 9,875 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $260,630 | 9,824 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $303,059 | 10,472 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $291,691 | 10,425 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $298,950 | 10,773 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $308,571 | 10,718 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $390,112 | 11,761 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $436,528 | 11,901 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $483,888 | 11,860 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $596,228 | 11,636 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $507,834 | 11,605 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $606,719 | 11,572 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $588,521 | 11,368 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $667,914 | 11,311 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $484,464 | 11,264 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $438,944 | 11,209 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $445,556 | 12,298 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $412,014 | 11,193 | Shares | Sole | 2021-03-03 | |
| 2020-09-30 | $407,332 | 11,099 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $359,994 | 11,009 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $356,265 | 10,915 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||